Patent Assignment
Reel/Frame 046749/0273
Change of Name
Recorded: 2018-08-08
Pages: 5
Assignor
SANGAMO BIOSCIENCES, INC.
Executed: 2017-01-05
Assignee
SANGAMO THERAPEUTICS, INC.
501 CANAL BLVD., SUITE A100, RICHMOND, CALIFORNIA, 94804
Covered Properties
(2)
Targeted Disruption of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases
Targeted Disruption of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2011
From: BONINI, MARIA CHIARA; GENOVESE, PIETRO; NALDINI, LUIGI; PROVASI, ELENA
To: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Reel/Frame 025982/0386 →
Assignment of Assignor's Interest
Mar 10, 2011
From: GREGORY, PHILIP D.; HOLMES, MICHAEL C.; PASCHON, DAVID; ZHANG, LEI
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 025982/0394 →
Transfer of Business
Feb 5, 2013
From: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
To: OSPEDALE SAN RAFFAELE S.R.L.
Reel/Frame 029752/0277 →